Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Short Term Open, Randomized Cross Over Trial Trial Exploring the Effect of Carbonic Anhydrase Inhibition by Acetazolamide on Sleep Apnea Associated Hypertension

NCT02220803 is registered in ClinicalTrials.gov with Göteborg University as lead sponsor.

NCT NCT02220803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02220803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Short Term Open, Randomized Cross Over Trial Trial Exploring the Effect of Carbonic Anhydrase Inhibition by Acetazolamide on Sleep Apnea Associated Hypertension
Lead sponsor
Göteborg University
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2014
Completion date
August 31, 2016
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood pressure, hypertension, obstructive sleep apnea, sleep-disordered breathing